Stifel Financial
GH icon

Stifel Financial’s Guardant Health GH Stock Holding History

Stifel Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37M Sell
29,131
-11,756
-29% -$1.28M ﹤0.01% 1495
2026
Q1 		$3.78M Sell
40,887
-2,080
-5% -$209K ﹤0.01% 1529
2025
Q4 		$4.39M Sell
42,967
-1,980
-4% -$177K ﹤0.01% 1409
2025
Q3 		$2.81M Sell
44,947
-1,977
-4% -$108K ﹤0.01% 1664
2025
Q2 		$2.44M Sell
46,924
-1,669
-3% -$74.5K ﹤0.01% 1702
2025
Q1 		$2.07M Sell
48,593
-1,334
-3% -$57.6K ﹤0.01% 1741
2024
Q4 		$1.53M Buy
49,927
+10,006
+25% +$281K ﹤0.01% 1965
2024
Q3 		$916K Sell
39,921
-234
-0.6% -$6.62K ﹤0.01% 2291
2024
Q2 		$1.16M Buy
40,155
+14,252
+55% +$332K ﹤0.01% 2073
2024
Q1 		$534K Sell
25,903
-45,887
-64% -$984K ﹤0.01% 2575
2023
Q4 		$1.94M Sell
71,790
-5,469
-7% -$143K ﹤0.01% 1688
2023
Q3 		$2.29M Sell
77,259
-6,328
-8% -$223K ﹤0.01% 1505
2023
Q2 		$2.99M Buy
83,587
+7,811
+10% +$224K ﹤0.01% 1357
2023
Q1 		$1.78M Buy
75,776
+8,003
+12% +$229K ﹤0.01% 1650
2022
Q4 		$1.84M Sell
67,773
-29,104
-30% -$1.33M ﹤0.01% 1577
2022
Q3 		$5.21M Buy
96,877
+9,442
+11% +$485K 0.01% 932
2022
Q2 		$3.53M Buy
87,435
+5,728
+7% +$284K 0.01% 1151
2022
Q1 		$5.41M Buy
81,707
+5,889
+8% +$403K 0.01% 1016
2021
Q4 		$7.58M Buy
75,818
+17,146
+29% +$1.77M 0.01% 863
2021
Q3 		$7.33M Sell
58,672
-4,466
-7% -$531K 0.01% 844
2021
Q2 		$7.84M Buy
63,138
+12,538
+25% +$1.69M 0.01% 798
2021
Q1 		$7.72M Buy
50,600
+3,658
+8% +$553K 0.01% 765
2020
Q4 		$6.05M Buy
46,942
+856
+2% +$98.5K 0.01% 798
2020
Q3 		$5.15M Sell
46,086
-1,006
-2% -$92K 0.01% 749
2020
Q2 		$3.82M Sell
47,092
-1,469
-3% -$118K 0.01% 837
2020
Q1 		$3.39M Buy
48,561
+45,400
+1,436% +$3.48M 0.01% 806
2019
Q4 		$251K Sell
3,161
-487
-13% -$35.1K ﹤0.01% 2635
2019
Q3 		$226K Sell
3,648
-8,267
-69% -$728K ﹤0.01% 2594
2019
Q2 		$1.03M Buy
+11,915
New +$910K ﹤0.01% 1780

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Stifel Financial's GH Position: Q2 2026 in Review

Stifel Financial reduced its Guardant Health (GH) stake by 29% in Q2 2026, selling an estimated $1.28M and leaving 29,131 shares worth $4.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Stifel Financial first reported a position in GH in Q2 2019 and has held it in 29 quarters since. The position peaked at $7.84M in Q2 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Stifel Financial held 29,131 shares of Guardant Health worth $4.37M as of Q2 2026.
  • Stifel Financial sold 11,756 Guardant Health shares in Q2 2026, an estimated $1.28M.
  • Guardant Health made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1495 holding.
  • Stifel Financial first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • Stifel Financial's Guardant Health position peaked at $7.84M in Q2 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.